Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_assertion type Assertion NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_head.
- NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_assertion description "[CSS has 2 major clinical subsets, antineutrophil cytoplasmic antibody (ANCA)-positive, with features of small-vessel vasculitis, and ANCA-negative, in which organ damage is mainly mediated by tissue eosinophilic infiltration; analysis of HLA-DRB4 in patients categorized by different numbers of vasculitic manifestations (purpura, alveolar hemorrhage, mononeuritis multiplex, rapidly progressive glomerulonephritis, and constitutional symptoms) showed that its frequency strongly correlated with the number of vasculitis symptoms (P for trend = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_provenance.
- NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_assertion evidence source_evidence_literature NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_provenance.
- NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_assertion SIO_000772 17763415 NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_provenance.
- NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_assertion wasDerivedFrom befree-2016 NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_provenance.
- NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_assertion wasGeneratedBy ECO_0000203 NP627679.RAUXIEc9LEPRBinQ081fRH4UglpoLW5N5xn_2u_MvQZ2Y130_provenance.